Search

Your search keyword '"Stroke (Disease) -- Drug therapy"' showing total 1,630 results
Start Over Descriptor "Stroke (Disease) -- Drug therapy"
1,630 results on '"Stroke (Disease) -- Drug therapy"'

1. Reports from Ochsner Clinic Foundation Describe Recent Advances in Health and Medicine (Precision in Stroke Care: A Novel Model for Predicting Functional Independence in Urgent Carotid Intervention Patients)

Subjects
Stroke (Disease) -- Drug therapy, Physical fitness -- Models -- Analysis -- Reports, Stroke patients -- Reports -- Models -- Analysis, Health
Abstract

2025 MAR 1 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Research findings on agriculture are discussed in a new report. According to [...]

Published
2025

3. Ege University Faculty of Medicine Researchers Target Venous Thromboembolism (Desensitization To Rivaroxaban in A Patient Who Experienced Anaphylactoid Shock After Anticoagulant Use: Case Report)

Subjects
Ege University, Drug therapy, College faculty, Physical fitness, Heart diseases -- Drug therapy, Thromboembolism -- Drug therapy, Anticoagulants, Stroke -- Drug therapy, Stroke (Disease) -- Drug therapy, Anticoagulants (Medicine), College teachers
Abstract

2025 JAN 18 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on venous thromboembolism have been presented. According to news reporting [...]

Published
2025

4. New technology improves stroke treatment

Subjects
Drug therapy, Innovations, Stroke -- Drug therapy, Stroke (Disease) -- Drug therapy
Abstract

Getting treatment during the first hour of a stroke is key to survival and recovery. To listen to this broadcast, click here: https://www.abc.net.au/listen/programs/worldtoday/new-technology-improves-stroke-treatment/104795758 [Transcript] Nick Grimm: Every year, nearly 40,000 [...]

Published
2025

5. Researcher from University of Belgrade Provides Details of New Studies and Findings in the Area of Gene Therapy (Exploring therapeutical targets and innovative treatments for ischemic stroke: a comprehensive review)

Subjects
University of Belgrade -- Reports, Drug therapy, Reports, Physical fitness -- Reports, Genetic research -- Reports, Gene therapy -- Reports, Genes -- Reports, Stroke -- Drug therapy, Ischemia -- Drug therapy, Stroke (Disease) -- Drug therapy
Abstract

2024 DEC 14 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on gene therapy. According to news originating from [...]

Published
2024

6. Data from Sichuan University Advance Knowledge in Stroke [Combined Selective Endovascular Brain Hypothermia With Edaravone Dexborneol Versus Edaravone Dexborneol Alone for Endovascular Treatment In Acute Ischemic Stroke (She): Protocol for a ...]

Subjects
Drug therapy, Physical fitness, Edaravone, Stroke -- Drug therapy, Ischemia -- Drug therapy, Stroke (Disease) -- Drug therapy
Abstract

2024 DEC 14 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on Cerebrovascular Diseases and Conditions - Stroke have been presented. [...]

Published
2024

7. Reports from University of Pennsylvania Provide New Insights into Liposomes (Nanocarriers' Repartitioning of Drugs Between Blood Subcompartments As a Mechanism of Improving Pharmacokinetics, Safety, and Efficacy)

Subjects
University of Pennsylvania, Drug therapy, Drug delivery systems, Physical fitness, Blood proteins, Drugs, Stroke -- Drug therapy, Stroke (Disease) -- Drug therapy, Drugs -- Vehicles
Abstract

2024 OCT 12 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in Biotechnology - Liposomes. According to news originating [...]

Published
2024

8. ASSOCIAÇÃO DE TRATAMENTOS PARA A FORMA GRAVE DE AVC ISQUÉMICO CAUSADO PELA OBSTRUÇÃO DA ARTÉRIA BASILAR /COMBINATION OF TREATMENTS FOR SEVERE ISCHAEMIC STROKE CAUSED BY BASILAR ARTERY OBSTRUCTION /ASOCIACIÃ'N DE TRATAMIENTOS PARA LA FORMA GRAVE DE AVC ISQUÉMICA CAUSADA POR LA OBSTRUCCIÃ'N DE LA ARTERIA BÁSICA

Author

de Oliveira, Nayla Pereira, Pereira, Gabriela Abreu, Oliveira, Julia, Duarte, Cecília Ribeiro, Brandão, Giovana Silveira, de Oliveira, Livia Pereira, Vilela, Bruna Bueno, Ampli, Fernanda Cristina Pinto Vida, and Gontijo, Allan Andrade

Published
2023
Full Text
View/download PDF

10. Studies from Donghua University in the Area of Stroke Reported (Phosphorus Dendrimers Co-deliver Fibronectin and Edaravone for Combined Ischemic Stroke Treatment Via Cooperative Modulation of Microglia/neurons and Vascular Regeneration)

Subjects
Drug therapy, Physical fitness, Edaravone, Fibronectins, Stroke -- Drug therapy, Dendrimers, Ischemia -- Drug therapy, Stroke (Disease) -- Drug therapy
Abstract

2024 SEP 7 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Data detailed on Cerebrovascular Diseases and Conditions - Stroke have been presented. [...]

Published
2024

11. Researcher from Xiamen Medical College Reports Recent Findings in Stroke (Application and Development of Cell Membrane Functionalized Biomimetic Nanoparticles in the Treatment of Acute Ischemic Stroke)

Subjects
Drug therapy, Reports, Physical fitness -- Reports, Biomimetics -- Reports, Cell death -- Reports, Biochemistry -- Reports, Nervous system diseases -- Drug therapy, Stroke -- Drug therapy, Ischemia -- Drug therapy, Stroke (Disease) -- Drug therapy
Abstract

2024 AUG 24 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Fresh data on stroke are presented in a new report. According to [...]

Published
2024

12. Researchers at UMass Chan Medical School Publish New Data on Cardiovascular Medicine (Association between deep neural network-derived electrocardiographic-age and incident stroke)

Subjects
Drug therapy, Neural network, Physical fitness, Artificial neural networks, Stroke -- Drug therapy, Stroke (Disease) -- Drug therapy, Neural networks
Abstract

2024 JUL 20 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on cardiovascular medicine is the subject of a new report. [...]

Published
2024

14. Data on Deglutition Disorders Described by Researchers at Second Affiliated Hospital (Meta Analysis of Electric Stimulation Rehabilitation Treatment for Dysphagia After Stroke)

Subjects
Drug therapy, Analysis, Physical fitness -- Analysis, Deglutition disorders -- Drug therapy, Medical research -- Analysis, Stroke -- Drug therapy, Stroke (Disease) -- Drug therapy, Medicine, Experimental -- Analysis
Abstract

2024 JUL 6 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Pharyngeal Diseases and Conditions - Deglutition Disorders have [...]

Published
2024

15. FDA Approves TNKase for Acute Ischemic Stroke

Subjects
Genentech Inc., Stroke (Disease) -- Drug therapy, Ischemia -- Drug therapy, Drug approval, Tenecteplase, News, opinion and commentary, Sports and fitness
Abstract

THURSDAY, March 6, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in [...]

Published
2025

17. FDA Approves Genentech's TNKase(r) in Acute Ischemic Stroke in Adults

Subjects
United States. Food and Drug Administration, Biological products industry, Stroke (Disease) -- Drug therapy, Ischemia -- Drug therapy, Drug approval, Adults, Tenecteplase, General interest, News, opinion and commentary, Activase (Medication)
Abstract

SOUTH SAN FRANCISCO: Genentech has issued the following news release: Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug [...]

Published
2025

18. FDA Approves Genentech's TNKase[R] in Acute Ischemic Stroke in Adults

Subjects
United States. Food and Drug Administration, Genentech Inc., Biological products industry, Stroke (Disease) -- Drug therapy, Ischemia -- Drug therapy, Drug approval, Adults, Tenecteplase, Business, Business, international, Activase (Medication)
Abstract

- TNKase([R]) (tenecteplase) is the first stroke medicine approved by the FDA in nearly 30 years - - Single five-second intravenous bolus provides faster and simpler administration than the approved [...]

Published
2025

19. Mayo Clinic Q and A: Clot buster? Surgery? What is the right treatment for stroke?

Subjects
Drug therapy, Surgery, Questions and answers, Stroke -- Drug therapy, Stroke (Disease) -- Drug therapy
Abstract

DEAR MAYO CLINIC: My neighbor had a https://www.mayoclinic.org/diseases-conditions/stroke/symptoms-causes/syc-20350113 and received a 'clot buster' medication. Then, I found out my uncle had a surgery after a stroke. Can you help me [...]

Published
2025

20. Imperative Care Secures FDA 510(k) Clearance for the Zoom System, Including the First Large-Bore .088' Catheter for Aspiration When Used with the Zoom Catheters, for Stroke Treatment

Subjects
United States. Food and Drug Administration, Drug therapy, Stroke -- Drug therapy, Stroke (Disease) -- Drug therapy
Abstract

Final Imperative Trial Data Show the Zoom System Delivered the Fastest Median Case Time in A Well-Controlled, Rigorous Study1 CAMPBELL, Calif. -- Imperative Care , Inc. today announced that it [...]

Published
2025

21. How AI Is Shaping The Future Of Stroke Treatment In The UK

Subjects
Drug therapy, Medical research, Stroke -- Drug therapy, Health care reform, Stroke (Disease) -- Drug therapy, Medicine, Experimental
Abstract

In the UK, it is estimated that 100,000 people suffer from strokes each year, equivalent to one stroke every five minutes. Research from the NHS demonstrates the life-changing aftermath they [...]

Published
2025

22. Impact of body mass index on efficacy and safety of ticagrelor versus clopidogrel in patients with minor stroke or transient ischemic attack

Author

Zhang, Jia, Wang, Anxin, Tian, Xue, Meng, Xia, Xie, Xuewei, Jing, Jing, Lin, Jinxi, Wang, Yilong, Li, Zixiao, Liu, Liping, Li, Hao, Jiang, Yong, Zhao, Xingquan, and Wang, Yongjun

Subjects
Testing, Drug therapy, Evaluation, Comparative analysis, Ticagrelor -- Testing -- Comparative analysis, Clopidogrel -- Testing -- Comparative analysis, Body mass index -- Evaluation, Stroke -- Drug therapy, Transient ischemic attack -- Drug therapy, Stroke (Disease) -- Drug therapy, Cerebral ischemia -- Drug therapy
Abstract

Trials of antithrombotic drugs have established the efficacy of dual antiplatelet therapy with clopidogrel and acetylsalicylic acid (ASA) or with ticagrelor and ASA for treating patients with minor ischemic stroke [...], Background: Body mass index (BMI) may affect the response to platelet P2[Y.sub.12] receptor inhibitors. We aimed to explore whether BMI influenced the efficacy and safety of ticagrelor and clopidogrel for secondary prevention of minor ischemic stroke or transient ischemic attack (TIA) among patients enrolled in the CHANCE-2 (Ticagrelor or Clopidogrel with Aspirin in High-Risk Patients with Acute Nondisabling Cerebrovascular Events II) trial. Methods: In a multicentre, randomized, double-blind, placebo-controlled trial, conducted in China, we randomized patients with minor stroke or TIA who carried the CYP2C19 loss-of-function allele to receive either ticagrelor acetylsalicylic acid (ASA) or clopidogrel-ASA. We classified patients into obese (BMI [greater than or equal to] 28) or nonobese (BMI < 28) groups. The primary efficacy outcome was stroke within 90 days, and the primary safety outcome was severe or moderate bleeding within 90 days. Results: Among 6412 patients, 876 were classified as obese and 5536 were classified as nonobese. Compared with clopidogrel-ASA, ticagrelor-ASA was associated with a significantly lower rate of stroke within 90 days among patients with obesity (25 [5.4%] v. 47 [11.3%]; hazard ratio [HR] 0.51, 95% confidence interval [CI] 0.30-0.87), but not among those in the nonobese group (166 [6.0%] v. 196 [7.0%]; HR 0.84, 95% CI 0.69-1.04) The interaction of treatment and BMI group was significant (p for interaction = 0.04). We did not observe any difference by BMI group in rates of severe or moderate bleeding (9 [0.3%] v. 10 [0.4%] in the non-obese group; 0 [0.0%] v. 1 [0.2%] in the obese group; p for interaction = 0.99). Interpretation: In this secondary analysis of a randomized controlled trial involving patients with minor ischemic stroke or TIA, compared with clopidogrel-ASA, patients with obesity received more clinical benefit from ticagrelor-ASA therapy than those without obesity. Trial registration: Clinical trials.gov, no. NCT04078737.

Published
2023
Full Text
View/download PDF

24. Researchers at University of Pittsburgh School of Medicine Publish New Study Findings on Stroke (Distal Medium Vessel Occlusion Strokes: Understanding the Present and Paving the Way for a Better Future)

Subjects
University of Pittsburgh. School of Medicine -- Reports, Drug therapy, Reports, Physical fitness -- Reports, Stroke -- Drug therapy, Stroke (Disease) -- Drug therapy
Abstract

2024 JUN 29 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A new study on stroke is now available. According to news reporting [...]

Published
2024

25. Reteplase Superior to Alteplase Within 4.5 Hours of Ischemic Stroke

Subjects
Drug therapy, Reports, Tissue plasminogen activator -- Reports, Reteplase -- Reports, Stroke -- Drug therapy, Ischemia -- Drug therapy, Stroke (Disease) -- Drug therapy
Abstract

HealthDay News — Reteplase is noninferior to alteplase for patients with ischemic stroke within 4.5 hours after symptom onset, according to a study published online June 14 in the New [...]

Published
2024

26. Several Drugs Linked to Risk for Aneurysmal Subarachnoid Hemorrhage

Subjects
Drug therapy, Reports, Subarachnoid hemorrhage -- Drug therapy, Drugs -- Reports, Stroke -- Drug therapy, Prescriptions (Drugs) -- Reports, Stroke (Disease) -- Drug therapy, Drugs -- Prescribing -- Reports
Abstract

HealthDay News — Several commonly prescribed drugs are associated with aneurysmal subarachnoid hemorrhage (aSAH), according to a study published online June 5 in Neurology. Jos P. Kanning, from the University [...]

Published
2024

29. Remedy Pharmaceuticals Receives FDA Guidance to Advance CIRARA for Treatment of Severe Stroke

Subjects
United States. Food and Drug Administration, Stroke (Disease) -- Drug therapy, Product development, Time to market, Business, News, opinion and commentary
Abstract

NEW YORK, Nov. 19, 2024 /PRNewswire/ -- Remedy Pharmaceuticals, a leader in stroke drug development, announced today that a Type C meeting held with the U.S. Food and Drug Administration [...]

Published
2024

30. Remedy Pharmaceuticals Announces FDA Orphan Drug Designation Granted for the Treatment of Large Territory Acute Ischemic Stroke with CIRARA

Subjects
United States. Food and Drug Administration, Stroke (Disease) -- Drug therapy, Ischemia -- Drug therapy, Orphan drugs, Business, News, opinion and commentary
Abstract

NEW YORK, Oct. 22, 2024 /PRNewswire/ -- Remedy Pharmaceuticals, a pioneer in stroke drug development, today announced that the U.S. Food and Drug Administration (FDA) Office of Orphan Products Division [...]

Published
2024

31. UCONN'S PROMISING STROKE MEDICINE ONE STEP CLOSER TO CLINICAL TRIAL TESTING

Subjects
Brain damage -- Drug therapy, Stroke (Disease) -- Drug therapy, Clinical trials, News, opinion and commentary, University of Connecticut
Abstract

STORRS, Conn. -- The following information was released by the University of Connecticut: Lauren Woods - Schools of Medicine and Dental Medicine NIH awards $2 Million more to UConn School [...]

Published
2024

32. Stryker Polska Sp. z o.o. secures contract for Disposable Non-Chemical Medical Consumables And Haematological Consumables - Task 6 - Disposable Equipment For Endovascular Treatment Of Ischemic Strokes And Cns Vascular Malformations

Subjects
Stroke (Disease) -- Drug therapy, Ischemia -- Drug therapy, Contract agreement, News, opinion and commentary
Abstract

Poland based Stryker Polska Sp. z o.o. has secured contract from Gornoslaskie Centrum Medyczne im. prof. Leszka Gieca slaskiego Uniwersytetu Medycznego w Katowicach for Disposable Non-Chemical Medical Consumables And Haematological [...]

Published
2024

33. Procardia Medical Sp. z o.o. secures contract for Disposable Non-Chemical Medical Consumables And Haematological Consumables - Task 5 - Disposable Equipment For Endovascular Treatment Of Ischemic Strokes And Cns Vascular Malformations

Subjects
Stroke (Disease) -- Drug therapy, Ischemia -- Drug therapy, Contract agreement, News, opinion and commentary
Abstract

Poland based Procardia Medical Sp. z o.o. has secured contract from Gornoslaskie Centrum Medyczne im. prof. Leszka Gieca slaskiego Uniwersytetu Medycznego w Katowicach for Disposable Non-Chemical Medical Consumables And Haematological [...]

Published
2024

35. Tufts University School of Medicine Researchers Describe Advances in Cervical Cancer (A case report of lung metastasis in a cervical cancer presenting as a consolidation)

Subjects
Oncology, Experimental, Stroke (Disease) -- Drug therapy, Metastasis -- Drug therapy, Cervical cancer -- Drug therapy, Cancer -- Research, Health, Women's issues/gender studies
Abstract

2024 MAR 14 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Research findings on cervical cancer are discussed in a new report. According to news [...]

Published
2024

36. Data from Zhuhai Interventional Medical Center Update Knowledge in Stroke (Application of stimuli-responsive nanomedicines for the treatment of ischemic stroke)

Subjects
Drug therapy, Physical fitness, Medical centers, Stroke -- Drug therapy, Ischemia -- Drug therapy, Stroke (Disease) -- Drug therapy
Abstract

2024 FEB 24 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on stroke have been published. According to news originating [...]

Published
2024

37. ASA: No Drop in Recurrent Stroke Seen With Apixaban After Cryptogenic Stroke

Subjects
Drug therapy, Reports, Apixaban -- Reports, Recurrence (Disease) -- Drug therapy, Medical societies -- Reports, Stroke -- Drug therapy, Stroke (Disease) -- Drug therapy, Diseases -- Relapse
Abstract

HealthDay News — For patients with recent cryptogenic stroke and evidence of atrial cardiopathy, the risk for recurrent stroke is not reduced with apixaban vs aspirin, according to a study [...]

Published
2024

38. Lumosa Therapeutics and CHI Memorial announce new study for acute stroke

Subjects
Drug therapy, Testing, Planning, Health care industry, Company business planning, Clinical trials -- Planning, Health care industry -- Planning, Combination drug therapy -- Testing, Pharmaceutical industry -- Planning, Stroke -- Drug therapy, Stroke (Disease) -- Drug therapy, Drug therapy, Combination -- Testing
Abstract

2024 FEB 17 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Lumosa Therapeutics (Lumosa; 6535.TWO), together with CHI Memorial have announced the initiation [...]

Published
2024

39. ASA: Adjuvant Methylprednisolone Role Examined in Acute Ischemic Stroke

Subjects
Drug therapy, Reports, Medical societies -- Reports, Glucocorticoids -- Reports, Stroke -- Drug therapy, Ischemia -- Drug therapy, Methylprednisolone -- Reports, Stroke (Disease) -- Drug therapy, Corticosteroids -- Reports
Abstract

HealthDay News — For patients with acute ischemic stroke secondary to large-vessel occlusion (LVO) undergoing endovascular thrombectomy, adjuvant low-dose methylprednisolone does not improve the degree of overall disability, according to [...]

Published
2024

40. Researchers at Zhejiang University School of Medicine Release New Study Findings on Neuroscience (The Diagnostic Model of Ligusticum Chuanxiong Hort. Against Cerebral Stroke Using Network Pharmacology and Transcriptomics Analyses)

Subjects
Drug therapy, Reports, Physical fitness -- Reports, Neurosciences -- Reports, Stroke -- Drug therapy, Stroke (Disease) -- Drug therapy
Abstract

2024 JAN 27 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on neuroscience is the subject of a new report. According [...]

Published
2024

41. Investigators from Charite University Hospital and School of Medicine Target Ischemia (How the Brain Impacts the Heart: Lessons From Ischaemic Stroke and Other Neurological Disorders)

Subjects
Drug therapy, Nervous system diseases -- Drug therapy, Stroke -- Drug therapy, Ischemia -- Drug therapy, Stroke (Disease) -- Drug therapy
Abstract

2024 DEC 16 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- Fresh data on Vascular Diseases and Conditions - Ischemia are presented in a new report. [...]

Published
2024

43. Shenyang Pharmaceutical University Reports Findings in Stroke (Novel Hybrids of 6-amino-3-n-butylphthalide and Neuroprotective Groups Against Ischemic Stroke)

Subjects
Drug therapy, Tissue plasminogen activator, Drug approval, Stroke -- Drug therapy, Ischemia -- Drug therapy, Stroke (Disease) -- Drug therapy
Abstract

2024 NOV 29 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators discuss new findings in Cerebrovascular Diseases and Conditions - Stroke. According to [...]

Published
2024

44. Study Findings on Neurology Described by Researchers at University of Bristol School of Medicine (Assessing insomnia after stroke: a diagnostic validation of the Sleep Condition Indicator in self-reported stroke survivors)

Subjects
Drug therapy, Analysis, Stroke patients -- Analysis, Insomnia -- Drug therapy, Stroke -- Drug therapy, Stroke (Disease) -- Drug therapy
Abstract

2024 NOV 22 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Researchers detail new data in neurology. According to news reporting out of Bristol, [...]

Published
2024

45. Study Data from Capital Medical University Update Understanding of Stroke (Beyond low-density lipoprotein cholesterol levels: Impact of prior statin treatment on ischemic stroke outcomes)

Subjects
Drug therapy, Mortality -- China, Mediation, Low density lipoproteins, Statins, Cholesterol, Stroke -- Drug therapy, Ischemia -- Drug therapy, Stroke (Disease) -- Drug therapy
Abstract

2024 NOV 15 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- A new study on stroke is now available. According to news originating from [...]

Published
2024

46. Zhejiang University Reports Findings in Hemiplegia (Efficacy and Safety of Using a Unilateral Lower Limb Exoskeleton Combined With Conventional Treatment In Post-stroke Rehabilitation: a Randomized Controlled Trial)

Subjects
Drug therapy, Reports, Clinical trials -- Reports, Hemiplegia -- Drug therapy, Rehabilitation -- Reports, Nervous system diseases -- Drug therapy, Stroke -- Drug therapy, Stroke (Disease) -- Drug therapy
Abstract

2024 NOV 1 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on Nervous System Diseases and Conditions - Hemiplegia. According [...]

Published
2024

47. New Findings from Capital Medical University in the Area of Stroke Published (Phosphatidylserine: A Novel Target for Ischemic Stroke Treatment)

Subjects
Drug therapy, Reports, Phospholipids -- Reports, Stroke -- Drug therapy, Ischemia -- Drug therapy, Stroke (Disease) -- Drug therapy
Abstract

2024 NOV 1 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on stroke. According to news originating from Beijing, People's [...]

Published
2024

48. Remedy Pharmaceuticals' CIRARA receives US FDA Orphan Drug Designation

Subjects
United States. Food and Drug Administration, Stroke (Disease) -- Drug therapy, Orphan drugs, Business
Abstract

M2 EQUITYBITES-October 23, 2024-Remedy Pharmaceuticals' CIRARA receives US FDA Orphan Drug Designation (C)2024 M2 COMMUNICATIONS http://www.m2.co.uk New York-based clinical-stage pharmaceutical company Remedy Pharmaceuticals announced on Tuesday that it has received [...]

Published
2024

49. Remedy Pharmaceuticals' CIRARA receives US FDA Orphan Drug Designation

Subjects
United States. Food and Drug Administration, Stroke (Disease) -- Drug therapy, Orphan drugs, Chemistry
Abstract

M2 PHARMA-October 23, 2024-Remedy Pharmaceuticals' CIRARA receives US FDA Orphan Drug Designation (C)2024 M2 COMMUNICATIONS New York-based clinical-stage pharmaceutical company Remedy Pharmaceuticals announced on Tuesday that it has received Orphan [...]

Published
2024

50. Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration

Subjects
United States. Food and Drug Administration, Stroke (Disease) -- Drug therapy, Food -- Safety and security measures, Business, News, opinion and commentary
Abstract

NANJING, China, Sept. 14, 2024 /PRNewswire/ -- On September 2, 2024, Simcere Pharmaceuticals Group Ltd. (2096.HK) announced that Sanbexin Sublingual Tablets (Edaravone and Dexborneol sublingual tablets), an innovative drug for [...]

Published
2024

Catalog

Books, media, physical & digital resources
See catalog results